New Delhi: Cipla/Moderna gets DCGA (Drugs Controller General of India) nod for import of COVID19 vaccine, Government to make an announcement soon: Sources
Moderna has proposed to launch a single-dose vaccine for the Indian market.
Cipla filed an application on Monday seeking permission for import of Moderna COVID-19 vaccine referring to DCGI notices dated April 15 and June 1 stating that if the vaccine is approved by the USFDA for EUA, the vaccine can be granted marketing authorization without bridging trial and assessment of safety data of first 100 beneficiaries of vaccines shall be submitted before rolling out in immunization programme.
This is a developing story; to be updated.
